DYNAVAX TECHNOLOGIES CORP — Director's Dealing 2023

Sep 5, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DYNAVAX TECHNOLOGIES CORP (DVAX)
CIK: 0001029142
Period of Report: 2023-09-01

Reporting Person: Novack David F (President & COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-09-01	Common Stock	M	20000	$5.42	Acquired	23187	Direct
2023-09-01	Common Stock	S	20000	$14.48	Disposed	3187	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-09-01	Stock Option (Right to Buy)	$5.42	M	20000	Disposed	2027-02-11	Common Stock (20000)	Direct

Footnotes

F1: The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on May 5, 2023.

F2: This transaction was executed in multiple trades at prices ranging from $14.40 to $14.55; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, Dynavax, or a security holder of Dynavax

F3: This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 12, 2020, and one thirty-sixth (1/36) of the shares subject to the option vesting on the last day of each month thereafter, providing further that the options are subject to approval by our stockholders of an increase in the number of shares available under the 2018 Equity Incentive Plan.

F4: Not applicable.